Jory Bell & Jen Nwankwo - Playground Global & 1910 Genetics
Funding Strategies in the Bio/Health Tech Sector
This discussion, captured on August 18, 2021, centers on the recent surge in venture capital investment within the biotechnology landscape.
Specifically, the conversation features 1910 Genetics, a company benefiting from this trend. It explores strategies for securing funding and maximizing its impact.
Insights from Jen Nwankwo and Jory Bell
Founder and CEO of 1910 Genetics, Jen Nwankwo, shares her experiences with fundraising. Alongside her, Jory Bell, an investor from Playground Global, provides valuable perspectives.
Their discussion focuses on navigating the complexities of the bio/health tech funding environment.
Key Topics Covered
- Fundraising Techniques: The conversation details effective methods for attracting venture capital in the biotechnology and health technology industries.
- Strategic Financing: Nwankwo and Bell outline how to leverage secured funding to achieve optimal company growth and development.
- Investor Perspectives: Bell offers insights into what investors look for when evaluating opportunities in the bio/health tech space.
The insights shared are particularly relevant given the substantial increase in VC money flowing into biotech firms over the past year and beyond.
Understanding these strategies is crucial for entrepreneurs and companies operating within this rapidly evolving sector.